Wuxi Biologics (Cayman)'s total assets for Q2 2024 were ¥56.11B, a decrease of -0.83% from the previous quarter. HK:2269 total liabilities were ¥11.46B for the fiscal quarter, a -8.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.